Heilen Biopharm Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 09-12-2024
- Paid Up Capital ₹ 0.10 M
as on 09-12-2024
- Company Age 9 Year, 5 Months
- Last Filing with ROC 31 Mar 2021
- Revenue 18.20%
(FY 2020)
- Profit 225.71%
(FY 2020)
- Ebitda 111.99%
(FY 2020)
- Net Worth 125.12%
(FY 2020)
- Total Assets 126.57%
(FY 2020)
About Heilen Biopharm
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rajeshkumar Chaudhary and Jigneshkumar Chaudhary serve as directors at the Company.
- CIN/LLPIN
U72300GJ2015PTC083933
- Company No.
083933
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Jul 2015
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Gandhi Nagar, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Heilen Biopharm Private Limited offer?
Heilen Biopharm Private Limited offers a wide range of products and services, including Essential & Aromatic Oils, Menthol, Herb Oil, Flavours & Aromatics, Dry Powder Flavours, Cooking Spices and Masala, Vegetable Powders, Seeds Oil and Fruit Oils, Cosmetics, Hair & Beauty Products, Hair Care Products.
Who are the key members and board of directors at Heilen Biopharm?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajeshkumar Chaudhary  | Director | 24-Jul-2015 | Current |
| Jigneshkumar Chaudhary | Director | 24-Jul-2015 | Current |
Financial Performance of Heilen Biopharm.
Heilen Biopharm Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 18.2% increase. The company also saw a substantial improvement in profitability, with a 225.71% increase in profit. The company's net worth Soared by an impressive increase of 125.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Heilen Biopharm?
In 2020, Heilen Biopharm had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ollcure Medexose Private LimitedActive 4 years 2 monthsRajeshkumar Chaudhary and Jigneshkumar Chaudhary are mutual person
- Eirestellar Private LimitedActive 3 years 11 months
Rajeshkumar Chaudhary and Jigneshkumar Chaudhary are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Heilen Biopharm?
Unlock and access historical data on people associated with Heilen Biopharm, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Heilen Biopharm, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Heilen Biopharm's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
